Should patients with CKD stage 5D and biochemical evidence of secondary hyperparathyroidism be prescribed calcimimetic therapy? An ERA-EDTA position statement
2015 · Nephrology Dialysis Transplantation · 25 citations
https://doi.org/10.1093/ndt/gfv050